KalVista Pharmaceuticals (KALV) Property, Plant & Equipment (Net) Growth (1y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -13.32% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 17.12% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -10.19% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 24.11% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.18% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.92% |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn | -1.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -1.57% |
| Apr 30, 2025 | -10.73% |
| Oct 31, 2024 | -18.51% |
| Jul 31, 2024 | -25.35% |
| Apr 30, 2024 | -24.46% |
| Jan 31, 2024 | -20.22% |
| Oct 31, 2023 | -18.24% |
| Jul 31, 2023 | -7.16% |
| Apr 30, 2023 | 35.35% |
| Jan 31, 2023 | 37.11% |
| Oct 31, 2022 | 40.37% |
| Jul 31, 2022 | 55.86% |
| Apr 30, 2022 | 21.61% |
| Jan 31, 2022 | 18.58% |
| Oct 31, 2021 | 15.40% |
| Jul 31, 2021 | -3.71% |
| Apr 30, 2021 | -12.33% |
| Jan 31, 2021 | -17.35% |
| Oct 31, 2020 | -20.13% |
| Jul 31, 2020 | -10.47% |
| Apr 30, 2020 | -15.33% |
| Jan 31, 2020 | -1.27% |
| Oct 31, 2019 | 2.12% |
| Jul 31, 2019 | -0.22% |
| Apr 30, 2019 | 31.43% |
| Jan 31, 2019 | 195.74% |
| Oct 31, 2018 | 284.72% |
| Jul 31, 2018 | 281.76% |
| Apr 30, 2018 | 1,792.78% |
| Jan 31, 2018 | 697.94% |
| Mar 31, 2016 | -51.37% |
| Dec 31, 2015 | 347.22% |